Staidson BioPharm(SZ:300204) 雪球·2025-06-03 08:37Market Overview - The three major A-share indices rebounded collectively, with the Shanghai Composite Index rising by 0.43%, the Shenzhen Component Index by 0.16%, and the ChiNext Index by 0.48% [1] - The total market turnover reached 11,638 billion, an increase of 4 billion from the previous day, with nearly 3,400 stocks rising [2] Gold Market - COMEX gold futures returned to above $3,400 per ounce, driven by a declining dollar index and increased demand for safe-haven assets [4] - The Chicago Fed President indicated that if trade-related uncertainties are resolved, the Federal Reserve could proceed with interest rate cuts in the next 15 months [4][5] Stablecoin Concept - A surge in stablecoin concept stocks was observed in the A-share market, with multiple stocks hitting the daily limit [7] - The Hong Kong government has officially enacted the Stablecoin Regulation, which is expected to facilitate the launch of compliant stablecoins by the end of the year [9] - The global stablecoin market has surpassed $250 billion, with a significant increase of over $40 billion since the end of 2024 [9] Innovative Pharmaceuticals - The innovative pharmaceutical sector continues to strengthen, with several stocks, including Shuyou Shen and Guanhao Bio, hitting the daily limit [12] - Shuyou Shen has seen a cumulative increase of 169.72% since May 21, with its market capitalization rising from under 3 billion to 15.19 billion [13] - The approval of 11 new innovative drugs by the National Medical Products Administration is expected to boost the performance of related companies [15]